![Jennifer Tousignant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Tousignant
Conseiller Juridique Général chez
VIRIDIAN THERAPEUTICS, INC.
Fortune : 61 564 $ au 31/05/2026
Profil
Jennifer Tousignant is Chief Legal Officer at Viridian Therapeutics, Inc. since 2024.
Former positions include Senior Vice President-Legal at Sana Biotechnology, Inc., Member-Global Launch Teams at Genzyme Corp., Head-Legal at Xilio Therapeutics, Inc. in 2020, and Chief Intellectual Property Counsel at Tesaro, Inc. from 2016 to 2019.
Education includes undergraduate studies at the University of Virginia and graduate studies at Suffolk University Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 3 494 ( 0 % ) | 61 564 $ | 31/05/2026 |
Postes actifs de Jennifer Tousignant
| Sociétés | Poste | Début |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Conseiller Juridique Général | 15/02/2024 |
Anciens postes connus de Jennifer Tousignant
| Sociétés | Poste | Fin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Conseiller Juridique Général | 01/11/2020 |
| TESARO INC | Conseiller Juridique Général | 01/10/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| SANA BIOTECHNOLOGY, INC. | Conseiller Juridique Général | - |
Formation de Jennifer Tousignant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suffolk University Law School
 Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Choisissez Zonebourse 
